In a report released yesterday, Lili (Aurélie) Nsongo from Leerink Partners maintained a Hold rating on Arcturus Therapeutics ( ARCT – Research Report ), with a price target of $63.00. Discover ...

Arcturus sets up cameras around the edges of baseball stadiums to capture real-time action and generate a 3D digital clone of ...

Nestled deep in the Nubian Desert of southern Egypt lies a prehistoric relic that has reshaped our understanding of ancient ...

The two brightest nighttime stars available in the Minnesota and Wisconsin sky are Sirius and Arcturus. April is the only ...

One of the first major meteor showers of the year will coincide with Earth Day this year, offering a heavenly experience for ...

In this interview, with ANOZIE EGOLE, the Managing Director of the NLNG Shipping and Marine Services Limited, Mr. Abdulkadir ...

Spread This NewsAl Jazeera Long-frozen relations between the United States and Zimbabwe may be thawing after the Southern ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

The past two weeks were almost entirely cloudy. Behind the clouds, we missed many beautiful events involving the moon, ...

Meanwhile Arcturus, a San Diego biotech working with messenger RNA (mRNA) therapies said it is working with Duke-NUS Medical School (Duke-NUS) to develop a coronavirus vaccine for Singapore.